PRMT5 and Merkel cell skin cancer: Given that neuroendocrine differentiation is associated with poor prognosis and therapy resistance in epithelial cancers (Balanis et al, 2019), elucidating PRMT5’s role in MCC may provide insights into splicing dysregulation underlying epithelial–neuroendocrine transition–associated therapy resistance.